Guardian Wealth Advisors (North Carolina)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$905K Sell
37,571
-1,598
-4% -$41.8K 0.05% 168
2026
Q1
$1.1M Buy
39,169
+92
+0.2% +$2.45K 0.07% 149
2025
Q4
$973K Sell
39,077
-3,123
-7% -$78.8K 0.06% 156
2025
Q3
$1.08M Buy
42,200
+718
+2% +$17.7K 0.07% 142
2025
Q2
$1.01M Buy
41,482
+449
+1% +$10.5K 0.07% 141
2025
Q1
$1.04M Buy
41,033
+871
+2% +$22.8K 0.08% 126
2024
Q4
$1.07M Buy
40,162
+176
+0.4% +$4.77K 0.08% 126
2024
Q3
$1.16M Sell
39,986
-10,652
-21% -$311K 0.12% 93
2024
Q2
$1.42M Sell
50,638
-3,864
-7% -$106K 0.17% 77
2024
Q1
$1.51M Buy
54,502
+3,276
+6% +$90.9K 0.19% 76
2023
Q4
$1.47M Buy
51,226
+1,827
+4% +$55.2K 0.22% 67
2023
Q3
$1.64M Buy
49,399
+1,004
+2% +$35.5K 0.28% 58
2023
Q2
$1.78M Buy
48,395
+22
+0% +$856 0.3% 41
2023
Q1
$1.97M Sell
48,373
-464
-1% -$20K 0.35% 32
2022
Q4
$2.5M Buy
48,837
+74
+0.2% +$3.55K 0.48% 26
2022
Q3
$2.13M Buy
48,763
+5,565
+13% +$270K 0.4% 28
2022
Q2
$2.27M Buy
43,198
+33,452
+343% +$1.7M 0.41% 25
2022
Q1
$505K Buy
9,746
+1,612
+20% +$83.6K 0.22% 84
2021
Q4
$480K Buy
+8,134
New +$403K 0.21% 92

Other funds holding PFE

Guardian Wealth Advisors (North Carolina)'s PFE Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) reduced its Pfizer (PFE) stake by 4.1% in Q2 2026, selling an estimated $41.8K and leaving 37,571 shares worth $905K. The position accounts for 0.05% of the portfolio, ranked #168.

Guardian Wealth Advisors (North Carolina) first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.5M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Guardian Wealth Advisors (North Carolina) held 37,571 shares of Pfizer worth $905K as of Q2 2026.
  • Guardian Wealth Advisors (North Carolina) sold 1,598 Pfizer shares in Q2 2026, an estimated $41.8K.
  • Pfizer made up 0.05% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q2 2026, its #168 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Guardian Wealth Advisors (North Carolina)'s Pfizer position peaked at $2.5M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.